Clinical Trials Browser

Phase 1/2 × INDUSTRY × ranpirnase × Clear all

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Phase 1/2 Completed

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections